Literature DB >> 16343374

Antiretroviral adherence in a resource-poor setting.

Catherine Orrell1.   

Abstract

Adherence is key to successful antiretroviral therapy (ART). Many countries with increased HIV prevalence and the greatest need for ART have limited health resources. Recent assumptions that the adherence required for successful ART will not be achieved in resource-poor settings have led to calls for caution in expanded access programs. New studies from Africa refute this, showing excellent adherence and virologic outcomes. Major factors contributing to adherence or nonadherence are whether the drug is accessed for free or is self-funded, patient preparedness for use of ART, stigmatization related to being HIV-positive, and ease of use of regimen.

Entities:  

Mesh:

Year:  2005        PMID: 16343374     DOI: 10.1007/s11904-005-0012-8

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  29 in total

1.  HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries.

Authors:  M Petrella; B Brenner; H Loemba; M A Wainberg
Journal:  Drug Resist Updat       Date:  2001-12       Impact factor: 18.500

2.  Adherence to HAART and its principal determinants in a cohort of Senegalese adults.

Authors:  Isabelle Lanièce; Mounirou Ciss; Alice Desclaux; Karim Diop; Fatou Mbodj; Barra Ndiaye; Omar Sylla; Eric Delaporte; Ibrahima Ndoye
Journal:  AIDS       Date:  2003-07       Impact factor: 4.177

3.  South Africa approves plan for universal access to antiretrovirals. Government also pledges to upgrade health system via recruitment and training of many health-care workers.

Authors:  Adele Baleta
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

4.  Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.

Authors:  Anthony D Harries; Patrick Gomani; Roger Teck; Olga Ascurra de Teck; Edwin Bakali; Rony Zachariah; Edwin Libamba; Andrina Mwansambo; Felix Salaniponi; Rex Mpazanje
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-12       Impact factor: 2.184

5.  Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil.

Authors:  L F Brigido; R Rodrigues; J Casseb; D Oliveira; M Rossetti; P Menezes; A J Duarte
Journal:  AIDS Patient Care STDS       Date:  2001-11       Impact factor: 5.078

6.  Preventing antiretroviral anarchy in sub-Saharan Africa.

Authors:  A D Harries; D S Nyangulu; N J Hargreaves; O Kaluwa; F M Salaniponi
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

7.  Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

Authors:  J Byakika-Tusiime; J H Oyugi; W A Tumwikirize; E T Katabira; P N Mugyenyi; D R Bangsberg
Journal:  Int J STD AIDS       Date:  2005-01       Impact factor: 1.359

8.  Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience.

Authors:  Serena P Koenig; Fernet Léandre; Paul E Farmer
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

9.  Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.

Authors:  Mariana A Hacker; Maya L Petersen; Melissa Enriquez; Francisco I Bastos
Journal:  Rev Panam Salud Publica       Date:  2004-08

Review 10.  HIV antiretroviral drug resistance in Africa.

Authors:  John N Nkengasong; Christiane Adje-Toure; Paul J Weidle
Journal:  AIDS Rev       Date:  2004 Jan-Mar       Impact factor: 2.500

View more
  20 in total

Review 1.  HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Authors:  Viviana Simon; David D Ho; Quarraisha Abdool Karim
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

Review 2.  Extending HIV care in resource-limited settings.

Authors:  Kara Wools-Kaloustian; Sylvester Kimaiyo
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

3.  Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option B+') in Malawi.

Authors:  Lyson Tenthani; Andreas D Haas; Olivia Keiser; Hannock Tweya; Andreas Jahn; Joep J van Oosterhout; Frank Chimbwandira; Zengani Chirwa; Wingston Ng'ambi; Alan Bakali; Sam Phiri; Landon Myer; Fabio Valeri; Marcel Zwahlen; Gilles Wandeler
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

4.  The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa.

Authors:  Peng Wu; Brent A Johnson; Jean B Nachega; Baohua Wu; Claudia E Ordonez; Anna Q Hare; Rachel Kearns; Richard Murphy; Henry Sunpath; Vincent C Marconi
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

5.  A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South Africa.

Authors:  Francois van Loggerenberg; Debra Gray; Santhanalakshmi Gengiah; Pinky Kunene; Tanuja N Gengiah; Kogieleum Naidoo; Alison D Grant
Journal:  AIDS Patient Care STDS       Date:  2015-02-18       Impact factor: 5.078

6.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

7.  Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda.

Authors:  Putu Duff; Walter Kipp; T Cameron Wild; Tom Rubaale; Joa Okech-Ojony
Journal:  J Int AIDS Soc       Date:  2010-09-23       Impact factor: 5.396

8.  Sexual and reproductive health and human rights of women living with HIV.

Authors:  Manjulaa Narasimhan; Mona Loutfy; Rajat Khosla; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-01       Impact factor: 5.396

Review 9.  The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.

Authors:  Hakim Sendagire; Philippa J Easterbrook; Immaculate Nankya; Eric Arts; David Thomas; Steven J Reynolds
Journal:  AIDS Rev       Date:  2009 Apr-Jun       Impact factor: 2.500

10.  Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial.

Authors:  Francois van Loggerenberg; Alison D Grant; Kogieleum Naidoo; Marita Murrman; Santhanalakshmi Gengiah; Tanuja N Gengiah; Katherine Fielding; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2015-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.